Previous studies have shown that histone deacetylase inhibitors (HDACis) can kill cancer cells. In addition, HDACis can induce mitotic catastrophe in cancer cells due to insufficient localization of chromosomal passenger complex (CPC) to the centromere. However, the mechanisms behind these phenomena remain unclear. In this study, we found that a HDACi, FK228, affected multiple epigenetic modification characteristics of the centromere, including enhanced acetylation of histone H3 lysine 9 (H3K9), decreased trimethylation of H3K9, and decreased phosphorylation of histone H3 serine 10 (H3S10) and centromere protein A (CENP-A). These epigenetic changes implied that H3K9 hyperacetylation inhibits the CPC recruitment, induces impaired centromere assembly and function, and eventually leads to aberrant mitosis. These data suggested that hypoacetylation of histone in the pericentromere is the most important landmark for recruiting CPC and leading to the mitotic catastrophe in HDACiinduced killing of cancer cells.
Introduction
The chromosomal passenger complex (CPC) is a group of proteins consisting of survivin, inner centromeric protein (INCENP), borealin, and aurora B kinase. These proteins are nuclear in G2 phase, associate with the length of the condensing chromosome in prophase, accumulate at the inner centromere in prometaphase and metaphase, then, leave the chromosome and transfer to the central spindle at anaphase onset, and concentrate in the midbody at cytokinesis [1] [2] [3] . A functional CPC is involved in coordinating the chromosomal and cytoskeletal events of mitosis, regulating kinetochore formation, spindle assembly checkpoint, assembly of a stable bipolar spindle, and cytokinesis completion [4] . It has been reported that mitotic defects are observed with depletion of individual CPC proteins [5] [6] [7] . Mitosis cell death-mitotic catastrophe is used to describe cell death that occurs during or after mitosis, usually featured with the formation of cells that contain multiple nuclei, improper segregation of chromosomes during sister chromatid separation, and G2/M phase arrest. Recently, mitotic catastrophe has been widely reported as an effect of conventional chemotherapeutic drug treatment, such as antimicrotubule agents and DNA-damaging drugs [8] . Histone deacetylase inhibitors (HDACis), such as depsipeptide (FK228), LAQ824, and Sulindac and Suberoylanilide hydroxamic acid (SAHA), are a promising class of high-efficiency and low-cytotoxicity anticancer agents with the potential activities of inhibiting cell growth, inducing cell differentiation and/or apoptosis in the treatment of solid and hematological malignancies [9] . FK228 has shown antiproliferative activity against human tumor cell lines, including non-small cell lung cancer, small cell lung cancer, stomach cancer, breast cancer, and colon cancer. The concentration of FK228 required to reduce cell survival by 50% (IC50) ranged from 0.56 to 5.9 nM after 4 day treatment. FK228 has lower toxicity against normal human or murine cell lines than toward tumor cells [10] . FK228 is a class I HDAC enzymes inhibitor [11] . Like other HDACis, FK228 can induce hyperacetylation of histone, which promotes the combination between transcription factors and DNA, and activates genes transcription, such as enhancing p21 CIP1/WAF1 expression [12] . In addition, FK228 can also enhance the acetylation of some important cellular non-histone proteins. Zhao et al. [13] demonstrated that FK228 could also activate p21 CIP1/ WAF1 by specifically enhancing p53 acetylation at K373/ K382 which was required for recruitment of p300 to the p21 CIP1/WAF1 promoter. FK228 also disrupts heat shock protein 90 (Hsp90) chaperone function via enhancing the acetylation of Hsp90 and Hsp70, leading to the degradation
of Hsp90 client proteins, including mutant p53, Raf-1, EGFR, ErbB2, Akt, and Bcr-Abl [14, 15] . Currently, FK228 is in phase II and III clinical trails to treat patients with T-cell lymphoma, chronic lymphocytic leukemia, acute myeloid leukemia or various refractory metastatic solid tumors [16] . A prior study showed that FK228 caused mitotic arrest through the formation of aberrant mitotic spindles, probably by interfering with chromosome attachment, but did not affect mitotic microtubules [17] .
A previous study showed that HDACis could increase the accumulation of acetylated histone H3 and H4, directly influencing chromatin structure and the binding of nucleosome to gene promoter elements [18] . In particular, the inhibition of HDAC activity by HDACis prevented sister chromatid separation, induced chromosome segregation defects [19] , and increased chromosomal instability by aberrantly regulating mitosis checkpoint activation [20] . In addition, Stevens et al. [21] and our previous work [22] demonstrated that HDACis could induce mitotic catastrophe due to insufficient localization of CPC to the centromere during mitosis. However, the specific mechanisms underlying these phenomena are not clear. The centromere is the conserved locus of chromosome structural elements, which is essential for adhesion and separation of duplicated sister chromatids, microtubule attachment, recruitment of heterochromatin, and mitotic checkpoint function [23] . Previous studies showed that centromeric chromatin had a distinct epigenetic modification pattern which is distinct from that of euchromatin and flanking heterochromatin [24] . These centromeric epigenetic characteristics include centromeric histone centromere protein A (CENP-A), and dimethylation of histone H3 lysine 4 (H3K4me2) [25] . Flanking the centromeric domain are blocks of pericentromeric heterochromatin that are marked by heterochromatin protein1 (HP1), hypoacetylation of histone H3 and H4, trimethylation of histone H3 lysine 9 (H3K9me3), and DNA cytosine methylation [26] . In addition, histone H3 serine 10 phosphorylation (H3S10ph) is an epigenetic modification of pericentromere confined to the pericentromeric regions during late G2 and decorates all chromosomes during all mitotic stages [27] . It is known that the centromeric localization of CPC is important for exerting its function, and the members of CPC complex need to cooperate to target the centromere at the right time. INCENP is in charge of stabilizing the complex, borealin acts to promote the binding of survivin to INCENP, whereas survivin is an important guide to mediate aurora B docking at the centromere during mitosis [28] . An interesting question is whether CPC needs some landmarks to guide its centromeric localization. A recent study showed that disruption of DNA methylation could inhibit aurora B targeting at the pericentromeres in G2 nuclei, supporting the idea that local intrinsic chromosomal epigenetic characteristics of the centromere were essential for the recruitment of CPC and for the regulation of its function [29] . In this study, we detected the changes of multiple pericentromeric epigenetic characteristics induced by FK228, and analyzed the effect of each change on CPC targeting at pericentromeres. Our study suggests that hypoacetylation of histone in the pericentromere may be the most important landmark for the recruitment of CPC and in leading to the mitotic catastrophe during HDACi-mediated killing of cancer cells.
Materials and Methods

Cells and drug treatment
The human non-small-cell lung cancer (NSCLC) lines A549 were obtained from American Type Culture Collection and cultured in Dulbecco's modified Eagle's medium supplemented with 10% fetal bovine serum, 2 mM L-glutamine, penicillin (100 U/ml), and streptomycin (100 U/ml).
FK228 and aurora B kinase inhibitor VX-680 were kindly provided by Dr David S. Schrump (Thoracic Oncology, Surgeon Branch, NIH/NCI). Chaetocin and taxol were purchased from Sigma (St. Louis, USA). Drugs in stock solution were prepared in dimethyl sulfoxide (DMSO) (Sigma). Cells were treated separately with 25 ng/ml FK228, 400 nM chaetocin, 150 nM VX-680, 33 nM taxol or DMSO as a control for the indicated time period.
Antibodies
Rabbit anti-Aurora B, anti-CENP-A, and mouse anti-INCENP antibodies were purchased from Abcam (Cambridge, UK). Rabbit anti-phospho-Histone H3 (Ser10) and anti-trimethyl-Histone H3 (Lys9) were from Upstate Biotechnology (Charlottesville, USA). Rabbit anti-acetylHistone H3 (ly9), anti-histone H3, and anti-HDAC6 antibodies were from Cell Signaling Technology (Beverly, USA). Human anti-nuclear ANA-centromere (CREST serum) was from Cortex Biochem (San Leandro, USA). Rabbit anti-survivin was from Santa Cruz Biotechnology (Santa Cruz, USA). Mouse anti-ac-tubulin was from Sigma. Fluorescein isothiocyanate (FITC)-conjugated secondary antibody was from Jackson ImmunoResearch Laboratories (West Grove, USA).
RNA interference
Human HDAC6 siRNA and non-silence control siRNA were purchased from Santa Cruz Biotechnology (Santa Cruz). Cells were transfected with 0.5 mg (40 pM) of the various dsRNA oligonucleotides using 7.5 ml RNAiFect Transfection reagent (QIAGEN, Valencia, USA) and replenished with growth medium after 4 h. Twenty-four hours later, cells were harvested, and then analyzed for FK228 kills cancer cells reduced HDAC6 levels by western blot or used for immunofluorescence staining.
Immunofluorescence microscopy and fluorescence signal intensity analysis Cells cultured on microscope slides were fixed in 4% paraformaldehyde, permeabilized with phosphate buffered saline (PBS) containing 0.25% Triton X-100 for 10 min. After being washed with PBS, the cells were incubated for 30 min with PBS containing 1% bovine serum albumin. Then cells were labeled with different primary antibodies for 1 h at room temperature or overnight at 48C, followed by 1 h incubation with FITC-conjugated secondary antibodies. DNA was counterstained with Hoechest 33258 (Sigma), and the slides were examined by fluorescent microscopy at 1000Â magnification under immersion oil with a Nikon Eclipse E40 fluorescent microscope or Zeiss 510 META.
Fluorescence signal intensity analysis was carried out as described by Johnson et al. [30] . Briefly, fluorescence signal intensities of kinetochore bound protein were quantified using SoftWoRx Explore 1.2 (Applied Precision, Issaquah, USA). The average pixel intensities from 30 kinetochore pairs from three controls or FK228 treated cells were measured and background pixel intensities were subtracted.
Western blot analysis and immunoprecipitation
Equal loading of proteins was measured using BCA protein assay kit (Pierce, Rockford, USA). The samples were resolved by SDS-PAGE and transferred to polyvinylidenefluoride membranes. Membranes were blocked with 5% low-fat dried milk in tris-buffered saline tween-20 (0.1% Tween 20 in PBS), incubated with relevant primary antibodies, followed by incubating with anti-mouse and HRP-conjugated anti-rabbit IgG secondary antibodies (Cell Signaling Technology), and developed using the SuperSignal West Dura Extended Duration Substrate (Pierce). For immunoprecipitation, cells were lysed on ice for 30 min with lysis buffer (10 mM Tris, 1 mM EGTA, 150 mM NaCl, 1% Triton X-100, 0.5% NP-40, 1 mM Na 3 O 4 , 1 mM PMSF). Cytosolic lysates (200 ml) containing 500 mg of total protein were mixed with anti-Survivin antibody. After overnight incubation at 48C, A/G Sepharose (Santa Cruz) was added to the lysates, followed by incubation for 3 h. The immunoprecipitates were washed and proteins were recovered by boiling beads in SDS sample buffer and analyzed by western blot analysis.
Nuclear/cytosol extraction The nuclear and cytosolic fractions of A549 cells were prepared using a Nuclear/Cytosol Extraction Kit (Applygen, Beijing, China) according to the manufacturer's instructions. The cytosol and chromosome fractions were then subjected to SDS-PAGE and western blot analysis.
Statistical analysis
All data represent at least three independent experiments and are expressed as mean + SD. Data were analyzed with MANOVA-Wilk's l test. A P-value of ,0.05 was considered to be statistically significant.
Results
FK228 changes centromeric and pericentromeric epigenetic modification
It is known that the lysine residue tails of histone can be modified in different ways, including acetylation, phosphorylation, methylation, and ubiquitination [31] . As an HDACi, FK228 has been previously proved to enhance histone acetylation [32] . To quantify the changes of epigenetic modification in histone H3 induced by FK228, we first detected the time-dependent alteration of histone H3 lysine 9 (H3K9) acetylation by performing double immunofluorescence staining using anti-acetyl-H3K9 antibody and CREST serum (a centromere marker). As shown in Fig. 1(A) , H3K9 acetylation (H3K9ac) was very weak in the control cells, and there was a time-dependent increase of H3K9ac following 6-24 h of treatment with FK228. Although H3K9 hyperacetylation did not concentrate at the centromeres, the overall enhanced levels of acetylation altered the acetylation status around centromeres, which were usually hypoacetylated [26] . H3K9 is a unique site because it can be modified by both acetylation and di-or trimethylation. Although previous studies showed that enhanced H3K9 acetylation had no effect on H3K9 dimethylation (H3K9me2) [33] , the impact of hyperacetylation on H3K9 trimethylation (H3K9me3) has not been examined. Next, we investigated whether FK228 can interfere with H3K9me3. The results showed that, in control cells, H3K9me3 distinctly concentrated around the centromere, consistent with the previous observation that trimethylated H3K9 was predominantly present at pericentromeric regions [34] . However, following FK228 exposure, the concentrated H3K9me3 staining around centromeres gradually reduced [ Fig. 1(B) ]. The time point of the H3K9me3 staining beginning to decline was coincident with enhanced H3K9ac staining. It is clear that enhanced acetylation disrupts the trimethylation modification on H3K9. This is reasonable as both modifications occur on the same lysine residue. The fluorescence quantitative analysis of H3K9ac and H3K9me3 confirmed that the two epigenetic modification changes were significant [ Fig. 1(C,D) ]. Then, we detected the change on phosphorylation of histone H3 serine 10 (H3S10ph), a neighbor site of H3K9. The result showed that, in control cells the H3S10ph mainly concentrated at pericentromeres, but just like the dynamic changes on H3K9me3, FK228 timedependently declined the H3S10ph at the pericentromeres FK228 kills cancer cells as well [ Fig. 2(A) ]. Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 [27] . Figure 2(B) showed the cells were co-stained with H3S10ph and cyclin B. Cyclin B was used to identify the cells in the G2 phase. As H3 was phosphorylated at Ser10 by aurora B kinase, next we detected the effect of FK228 on phosphorylation of CENP-A, another substrate of aurora B. The result showed that following FK228 treatment, the phosphorylation of CENP-A at the centromeres was also declined [ Fig. 2(C) ], although the CENP-A staining was unaffected [ Fig. 2(D) ]. The results of Fig. 2(A,C) indicated that FK228 might inhibit aurora B kinase activity.
Then, we detected the changes in the above proteins via western blot analysis using nuclear protein obtained with a Nuclear/Cytosol Extraction kit. As shown in Fig. 3(A) , the protein level of H3K9ac was increased in a time-dependent manner after FK228 treatment and the trend of change was quite similar to that observed by immunofluorescence analysis [ Fig. 1(A) ]. However, the protein levels of H3K9me3 and H3S10ph did not show any remarkable change, indicating that the decreased levels of H3K9me3 and H3S10ph at pericentromeres were not caused by decreased protein expression. FK228 also induced remarkable depletion of survivin and aurora B [ Fig. 3(A) ], but aurora B depletion happened much later, at 48 h of drug exposure. Because the decreased H3S10ph and CENP-A phosphorylation occurred early [ Fig. 2(A,C) ], a time-point at which the changes could not be induced by aurora B protein depletion, we assume that FK228 may indirectly affect aurora B activity via other pathways. anaphase, and formation of multinuclear cells, all of which accompany the mislocalization of CPC at centromeres [15, 22] . To further determine the correlation between the changed epigenetic characteristics with the dynamic localization changes of CPC at the centromeres, the timedependent effect of FK228 on A549 cells was examined by immunofluorescent analysis using antibodies against survivin, aurora B, borealin, and INCENP from 0 to 24 h. Figure 3 (B,C) showed that following FK228 exposure, both aurora B and survivin gradually lost their centromeric localization. These alterations are consistent among all CPC proteins (data for borealin and INCENP not shown). Immunofluorescence quantitative analysis showed that following FK228 exposure, the amount of Survivin localized at the centromeres was reduced to 65% of the control group at 12 h and was nearly undetectable at 24 h [ Fig. 3(D) ]. The diminishing tendency of aurora B was similar to that of survivin (data not shown). The time-point at which aurora B lost its localization at the centromeres was coincident with that of decreased H3S10ph, supporting the idea that FK228 inhibited H3S10ph indirectly by disturbing aurora B localization at centromeres.
Along with the dynamic mislocalization of CPC members on centromeres, the number of multinuclear cells also showed a time-dependent increase in FK228-treated cells [ Fig. 4(A) ]. Analysis of the mitotic index indicated that FK228 treatment caused an increase in the number of prometaphase cells and a decrease of metaphase, anaphase, and telophase cells [ Fig. 4(B) ]. Figure 4 (C) showed FK228 inhibited the survival of A549 cells. The FACS results of Figure 4 (D) confirmed that FK228 induced obvious G2/M phase arrest of A549 cells. Thus, the data suggest that FK228 kill A549 cells through inducing mitotic catastrophe. In addition, all these phenomena were consistent with previous studies obtained with RNA interference (RNAi) or inhibitors against members of the CPC [5] [6] [7] , supporting the conclusion that the delocalization of CPC proteins from centromeres contributes to mitotic catastrophe.
Mislocalization of CPC is not caused by disassociation of the CPC complex, enhanced tubulin acetylation, or decreased H3K9me3 and H3S10ph FK228 has been reported previously to inhibit heat shock protein 90 (Hsp90) chaperone function and induce degradation of its client proteins via enhancing Hsp90 acetylation [14] . Although both survivin and aurora B kinase were Hsp90 client proteins [35, 36] , the possibility that FK228 interfered with CPC targeting at centromeres by inhibiting the Hsp90 chaperone function was excluded, Fig. 3(A) ]. This is later than the point at which CPC proteins lost their ability to target centromeres [ Fig. 3(B,C) ]. Previous studies showed that the individual protein of CPC and the interactions within the passenger proteins were important for CPC targeting at the centromeres [28, 37] . To further investigate whether FK228 influences the formation of the CPC, immunoprecipitation experiments were performed. As shown in Fig. 5(A) , FK228 did not affect the binding among survivin, aurora B, and INCENP, indicating that the mislocalization of CPC on centromeres was not caused by the disassociation of these proteins from the complex.
Microtubules are essential components of diverse structures in eukaryotic cells, playing important roles in ciliary beating, cell division, and intracellular trafficking. Microtubules are built by the polymerization of a-b-tubulin heterodimers, yet subpopulations of microtubules can be differentially marked by a number of post-translational modifications, such as acetylation and polyglutamylation [38] . It has been known that acetylation enhances microtubule stability [39] . Previous studies have shown that HDACis can increase the acetylation of tubulin by inhibiting HDAC6, a cytoplasmic microtubule-associated deacetylase of the class IIB family of HDACs [40] . Because CPC proteins are microtubule-associated proteins, we questioned whether the acetylation of tubulin would directly interfere with the dynamic centromeric localization of CPC. Using the RNAi technique, HDAC6 was inhibited in A549 cells and the level of tubulin acetylation was increased [ Fig. 5(B) ]. However, under this condition, the centromeric localization of aurora B did not show any obvious change [ Fig. 5(C) ]. This result was further confirmed by treating the cells with taxol that was known to stabilize microtubules via a-tubulin acetylation [39] . As shown in Fig. 5(D) , taxol did not affect aurora B localization at the centromeres. These data indicated that acetylation of tubulin did not interfere with the centromeric localization of CPC.
Next, we evaluated the effect of the FK228-induced decrease of H3K9me3 and H3S10ph on CPC localization. A549 cells were treated with chaetocin, a specific inhibitor of the lysine-specific histone methyltransferase Suv39H1 [41] , or VX-680, a known Aurora kinase inhibitor [42] , and the changes in Aurora B, H3K9me3 and H3S10ph were Fig. 6(A,B) ], both chaetocin and VX-680 treatments did not affect aurora B localized at centromeres [ Fig. 6(C) ]. These results suggest that inhibition of either H3K9me3 or H3S10ph does not affect aurora B centromeric localization. 
FK228 kills cancer cells
Discussion
It is known that CPC proteins play pivotal roles in mitosis, including chromatin modification, kinetochore attachment, spindle assembly checkpoint, stable bipolar spindle formation, and completion of cytokinesis [4] . Previous studies have shown that following HDACi treatment, cancer cells show various mitotic defects due to the lack of centromeric accumulation of the active CPC in mitosis [21, 22] , but the mechanism behind this phenomenon is undefined. As a kind of centromeric protein, the transient association of CPC proteins with the centromere is important for their multiple mitotic functions [43] . It is known that a ternary sub-complex of borealin, survivin, and the N-terminus of INCENP is essential and sufficient for the centromeric targeting of the CPC [37] . Furthermore, survivin is an important mediator of centromere and midbody docking of aurora B during mitosis [28] . Obviously, any change in the stability of either CPC proteins or CPC complex will affect its recruitment to the centromere. To exclude the possibility that HDACis may disrupt the formation of the CPC complex, immunoprecipitation and western blot analyzes were performed. Our data clearly showed that FK228 did not interfere with the interaction of the CPC proteins. Although a previous study reported that HDACi did not affect the levels of CPC proteins [21] , our data showed that FK228 could deplete both survivin and aurora B proteins, which might be induced by inhibiting the Hsp90 function [14] . However, because the CPC mislocalization occurred prior to survivin and aurora B protein depletion, it seemed that the inhibition of Hsp90 chaperone function could not be the main mechanism by which FK228 disturbed CPC localization. The potential involvement of enhanced microtubule stability induced by a-tubulin acetylation was also excluded, as knockdown of HDAC6 and treatment of cells with taxol, a known reagent to increase microtubule stability, had no effect on CPC localization.
Epigenetic control, including DNA methylation and histone modifications, participates in the processes crucial for mammalian development, such as X-chromosome inactivation and genomic imprinting. Epigenetics also play a key, but poorly understood, role in centromere function [44] . Previous evidence suggested that histone posttranslational modifications participated in building up local chromatin environments [31] . CENP-A plays indirect and direct roles in providing a permissive chromatin environment for the binding of aurora B, INCENP or survivin [45] . Disruption of DNA methylation inhibits pericentromeric targeting of aurora B and phosphorylation of H3 at Ser10 in G2 nuclei [29] . In addition, a previous study in budding yeast showed that yeast histone acetyltransferaseGcn5p played an important role in centromere function [46] . The above-described studies indicated the important role of local centromere epigenetic environments in maintaining centromere function and centromere protein localization. In this study, we observed that FK228 induced a series of changes on centromeric and pericentromeric epigenetic markers, including enhanced H3K9ac, declined H3K9me3, decreased H3S10ph, and decreased CENP-A phosphorylation. It is known that H3K9me3 is an important epigenetic characteristic for recruiting HP1 to chromatin during interphase, whereas H3S10ph is in charge of mitotic release of HP1 from chromatin. H3K9me3 and H3S10ph form the 'methyl/phos switching' which FK228 kills cancer cells dynamically controls the HP1-H3K9me3 interaction [47] . We assumed that the declined H3K9me3 around centromeres was caused by enhanced H3K9 acetylation, as both modifications happened on the same site. Recently, Wu et al. [48] demonstrated that FK228 could induce expression of a silenced gene by suppressing histone methyltransferases G9A and SUV39H1, which lead to decreased di-and tri-methylated H3K9 around these genes' promoters, and reduced the binding of HP1 protein. They also showed that a low dose of FK228 (5 nM) could induce suppression of histone methyltransferases which was happened late until drug exposure for 48-96 h. However, in our system, A549 cells were treated with higher-concentration FK228 (about 47 nM). The acetylation of H3K9 increased after 6 h FK228 treatment. The exposure to drug longer than 24 h led to significant cell death, therefore we did not think the decreased H3K9me3 around centromeres was induced by FK228-mediated suppression of histone methyltransferases G9A and SUV39H1. The unchanged H3K9me2 also supported this assumption.
As reported in other studies, FK228-induced changes on the 'methyl/phos switching' disturb HP1 recruitment and release from the chromatin, which aggravates the abnormal mitosis [19, 33, 49, 50] . However, it is unlikely that the FK228-induced decrease of H3K9me3 and H3S10ph is the cause for leading CPC mislocalization, because neither the specific Suv39H1 inhibitor chaetocin nor aurora B kinase inhibitor VX-680 could disrupt aurora B localization. CENP-A is the core epigenetic marker of centromeres and is phosphorylated at Ser7 by aurora B [45] . It has been proposed that aurora B maintains the phosphorylated status of CENP-A during mitosis, and in turn CENP-A phosphorylation in prophase is essential for aurora B localization at the centromeres [51] . Zeitlin et al. [45] reported that dominantnegative phosphorylation site mutants of CENP-A resulted in a delay at the terminal stage of cytokinesis. In addition, our previous study showed that FK228 could inhibit the localization and expression of Aurora A [22] . Therefore, decreased phosphorylation of CENP-A may partially contribute to the mislocalization of aurora B and the inhibition of aurora A by FK228.
Aurora B is an evolutionarily conserved serine-threonine kinase, whose activity is required for proper mitosis and cytokinesis [52] . There are conflicting reports regarding whether the centromeric association of aurora B is dependent on its kinase activity or not [53, 54] . Besides INCENP and survivin, histone H3 and CENP-A are also the substrates of aurora B kinase [45] . A previous study reported that HDACi did not affect aurora B kinase activity [33] . Our data showed that FK228 induced a decrease of both H3S10ph and CENP-A phosphorylation at the centromeres, but did not change the H3S10ph protein level [Figs. 2(A,C) and 3(A) ]. From these data, we concluded that FK228 might indirectly affect aurora B kinase activity by interfering with aurora B recruitment to the centromeres.
In summary, our results highlighted that the HDACi FK228 kills the human NSCLC cells by mistargeting CPC localization and inducing mitotic catastrophe, which also provides a mechanism of HDACi in the killing cancer cells. The mechanism involves changing multiple pericentromere epigenetic characteristics, including enhancing H3K9ac, decreasing H3K9me3, and decreasing phosphorylation of H3S10ph and CENP-A. However, only the enhanced acetylation of H3K9 seems to be the key epigenetic marker that correlates with aberrant CPC localization, suggesting that hypoacetylation of histone in the pericentromere is the most important landmark for recruiting CPC and leading to the mitotic catastrophe for HDACi-mediated killing of cancer cells.
